Abstract
IntroductionAdvanced therapies (AT), comprising biologics and small molecules, are key treatments of inflammatory bowel disease (IBD) and to avoid potentially serious immunosuppressive side-effects patients undergo pre-treatment infection screening to identify...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have